NCT05341193 2022-04-22
PD-1 Blockade and Bevacizumab Replace Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 1/2 Unknown
Clinical Trials
7 trialsNCT02915432 2021-12-13
The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCC
Shanghai Junshi Bioscience Co., Ltd.
Phase 1/2 Unknown
NCT03701451 2018-10-10
Demethylated Drug in the Treatment of Nasopharyngeal Carcinoma
Guilin Medical University, China
Phase 1/2 Unknown
NCT03639467 2018-09-18
Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal Carcinoma
ChineseAMS
Phase 1/2 Unknown
NCT03044743 2017-05-02
PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 1/2 Unknown
NCT03047525 2017-02-09
Study of DC-CTL Combined With CIK for Advanced Solid Tumor
Harbin Medical University
Phase 1/2 Unknown
NCT02980315 2016-12-02
A New EBV Related Technologies of T Cells in Treating Malignant Tumors and Clinical Application
The Second Hospital of Nanjing Medical University
Phase 1/2 Unknown